Phenotype: decreased T cell number
Definition fewer than normal T cell numbers
Synonyms
- reduced T-cell count
- reduced T-cell count
- reduced T lymphocyte number
- reduced T lymphocyte number
- reduced T cell number
- decreased T-cell number
- reduced T-cell number
- reduced T-lymphocyte number
- decreased T-cell count
- decreased T cell count
Related
Synonyms
Synonyms
- Absence of CD8-positive T cells
- Absence of CD8-positive T cells
- Decreased proportion circulating T-helper cells
- Decreased proportion circulating T-helper cells
- Decreased proportion of CD3-positive T cells
- Decreased proportion of CD4-positive T cells
- Decreased proportion of CD8-positive T cells
- absent CD4-positive, alpha beta T cells
- absent CD8-positive, alpha-beta T cells
- absent NK T cells
- absent T cells
- absent alpha-beta T cells
- absent double-negative T cells
- absent gamma-delta T cells
- absent mature gamma-delta T cells
- absent regulatory T cells
- decreased CD4-negative NK T cell number
- decreased CD4-positive NK T cell number
- decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
- decreased CD4-positive, alpha beta T cell number
- decreased CD4-positive, alpha-beta memory T cell number
- decreased CD5-positive gamma-delta T cell number
- decreased CD8-positive, CD25-positive alpha-beta T cell number
- decreased CD8-positive, alpha-beta T cell number
- decreased CD8-positive, alpha-beta memory T cell number
- decreased CD8-positive, naive alpha-beta T cell number
- decreased DN1 thymic pro-T cell number
- decreased DN2 thymocyte number
- decreased DN3 thymocyte number
- decreased DN4 thymocyte number
- decreased KLRG1+ CD4 alpha beta T cell number
- decreased KLRG1+ CD8 alpha beta T cell number
- decreased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
- decreased KLRG1-positive gamma-delta T cell number
- decreased Ly6C-positive NK T cell number
- decreased NK T cell number
- decreased T follicular helper cell number
- decreased T helper 1 cell number
- decreased T-helper 17 cell number
- decreased T-helper 2 cell number
- decreased T-helper cell number
- decreased Tc17 cell number
- decreased activated T cell number
- decreased alpha-beta T cell number
- decreased central memory CD4-positive, alpha-beta T cell number
- decreased central memory CD8 positive, alpha-beta T cell number
- decreased dendritic epidermal T cell number
- decreased double-negative T cell number
- decreased double-positive T cell number
- decreased effector memory CD4-positive, alpha-beta T cell number
- decreased effector memory CD8-positive, alpha-beta T cell number
- decreased gamma-delta T cell number
- decreased gamma-delta intraepithelial T cell number
- decreased mature gamma-delta T cell number
- decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
- decreased memory T cell number
- decreased memory-marker gamma-delta T cell number
- decreased regulatory T cell number
- decreased single-positive T cell number
- decreased thymocyte number
- increased dendritic epidermal T cell number
Procedure
- Immunophenotyping (IMPC, v1)
- Bone marrow immunophenotyping (MGP, v1)
- Buffy coat peripheral blood leukocyte immunophenotyping (MGP, v1)
- Ear epidermis immunophenotyping (MGP, v1)
- FACS (HRWL, v1)
- FACS (ICS, v1)
- FACs Analysis (ESLIM, v1)
- FACs Analysis (M-G-P, v1)
- Immunophenotyping (ICS, v2)
- Immunophenotyping (TCPLA, v1)
- Immunophenotyping (UCDLA, v1)
- Immunophenotyping (HMGULA, v1)
- Immunophenotyping (RBRCLA, v1)
- Mesenteric Lymph Node Immunophenotyping (MGP, v1)
- Spleen Immunophenotyping (MGP, v1)
- Whole blood peripheral blood leukocyte immunophenotyping (SLM, v1)
- Whole blood peripheral blood leukocyte immunophenotyping (MGP, v1)
MP browserMP:0005018
Phenotype associations stats
7.40% of tested genes with null mutations on a B6N genetic background have a phenotype association to decreased T cell number (115/1554)
4.98% females (74/1485) 4.74% males (72/1520)
Select a parameter
Gene variants with decreased T cell number
Total number of significant genotype-phenotype associations: 395
Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Procedure | Parameter | Phenotyping Center | Source | P Value | Data |
---|---|---|---|---|---|---|---|---|
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell number | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Arhgap30 Arhgap30^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-positive NK T cell number | Spleen Immunophenotyping | Resting CD4+ NKT cells - % of CD4+ NKT cells | WTSI | 3i | 0.0 | ||
Arhgef1 Arhgef1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 0.0 | ||
Brd2 Brd2^{em1(IMPC)Wtsi} |
HET | postnatal | decreased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-positive NK T cell number | Spleen Immunophenotyping | Effector CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Effector CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Effector CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive NK T cell number | Spleen Immunophenotyping | Total CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased NK T cell number | Spleen Immunophenotyping | Total NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-positive NK T cell number | Mesenteric Lymph Node Immunophenotyping | Effector CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-negative NK T cell number | Mesenteric Lymph Node Immunophenotyping | Effector CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased memory-marker gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased NK T cell number | Mesenteric Lymph Node Immunophenotyping | Total NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Spleen Immunophenotyping | CD4+ T helper cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive NK T cell number | Spleen Immunophenotyping | Total CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Spleen Immunophenotyping | Total T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cog6 Cog6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Cpgi5563 Cpgi5563^{tm1.1(NCC)WCS} |
HOM | postnatal | decreased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Bone marrow immunophenotyping | T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Cxcr2 Cxcr2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
D6Wsu163e D6Wsu163e^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 0.0 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 0.0 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 0.0 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 0.0 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Mesenteric Lymph Node Immunophenotyping | Total NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Dph6 Dph6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Spleen Immunophenotyping | CD4+ T helper cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased memory-marker gamma-delta T cell number | Spleen Immunophenotyping | Effector gd T cells - % of gd T cells | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Resting Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Gda Gda^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Mesenteric Lymph Node Immunophenotyping | CD4+ T helper cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gimap6 Gimap6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Effector CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gimap6 Gimap6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-negative NK T cell number | Spleen Immunophenotyping | Total CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased KLRG1+ CD8 alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | KLRG1+ CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Spleen Immunophenotyping | CD4+ T helper cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-positive NK T cell number | Spleen Immunophenotyping | Effector CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Effector Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Resting CD4- NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive NK T cell number | Spleen Immunophenotyping | Total CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Spleen Immunophenotyping | Total Treg cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased memory-marker CD4-negative NK T cell number | Mesenteric Lymph Node Immunophenotyping | Effector CD4- NKT cells - % of CD4- NKT cells | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Hbs1l Hbs1l^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Spleen Immunophenotyping | CD4+ T helper cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 0.0 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 0.0 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 0.0 | ||
Mkrn2 Mkrn2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased dendritic epidermal T cell number | Ear epidermis immunophenotyping | DETC coverage | WTSI | 3i | 0.0 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 0.0 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 0.0 | ||
Nrbp1 Nrbp1^{tm3b(EUCOMM)Wtsi} |
HET | postnatal | decreased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Pclaf Pclaf^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Bone marrow immunophenotyping | T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Pclaf Pclaf^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Pepd Pepd^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased Ly6C-positive NK T cell number | Spleen Immunophenotyping | Ly6C+ NKT cells - % of lymphocytes | WTSI | 3i | 0.0 | ||
Phf8 Phf8^{em2(IMPC)Wtsi} |
HEM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Rwdd1 Rwdd1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Rwdd1 Rwdd1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 0.0 | ||
Sgsm1 Sgsm1^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased T-helper cell number | Mesenteric Lymph Node Immunophenotyping | CD4+ T helper cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased gamma-delta T cell number | Mesenteric Lymph Node Immunophenotyping | Total gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD5-positive gamma-delta T cell number | Spleen Immunophenotyping | CD5+ gd T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased memory-marker CD4-positive NK T cell number | Spleen Immunophenotyping | Effector CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased memory-marker CD4-negative NK T cell number | Spleen Immunophenotyping | Effector CD4- NKT cells - % of CD4- NKT cells | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD4-positive NK T cell number | Spleen Immunophenotyping | Total CD4+ NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased NK T cell number | Spleen Immunophenotyping | Total NKT cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased alpha-beta T cell number | Spleen Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Sik3 Sik3^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 0.0 | ||
Tmem126a Tmem126a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Spleen Immunophenotyping | CD4+ T helper cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem126a Tmem126a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Spleen Immunophenotyping | Total CD4+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem126a Tmem126a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Spleen Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Mesenteric Lymph Node Immunophenotyping | Resting CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Tmem127 Tmem127^{tm1(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Mesenteric Lymph Node Immunophenotyping | Total CD4+ T cells - % of ab T cells | WTSI | 3i | 0.0 | ||
Traf2 Traf2^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased CD8-positive, alpha-beta T cell number | Spleen Immunophenotyping | Total CD8+ T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Traf2 Traf2^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased alpha-beta T cell number | Spleen Immunophenotyping | Total ab T cells - % of CD45+ | WTSI | 3i | 0.0 | ||
Upk1b Upk1b^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 0.0 | ||
Vps13a Vps13a^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased T-helper cell number | Mesenteric Lymph Node Immunophenotyping | CD4+ T helper cells - % of CD4+ | WTSI | 3i | 0.0 | ||
Zc3h14 Zc3h14^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 0.0 | ||
Cd28 Cd28^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | MRC Harwell | EuroPhenome | 3.99E-28 | ||
Spns2 Spns2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 1.15E-25 | ||
Elk4 Elk4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | HMGU | EuroPhenome | 2.12E-21 | ||
Elk4 Elk4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | HMGU | EuroPhenome | 8.19E-19 | ||
Cybc1 Cybc1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 2.94E-17 | ||
Tmem189 Tmem189^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 1.28E-15 | ||
Trex1 Trex1^{tm1(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 4.97E-15 | ||
Spns2 Spns2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 5.37E-15 | ||
Tcf7 Tcf7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | ICS | MGP | 1.27E-13 | ||
Spns2 Spns2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 1.34E-13 | ||
Tmem189 Tmem189^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 3.46E-13 | ||
Elk4 Elk4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | HMGU | EuroPhenome | 6.01E-13 | ||
Sgms1 Sgms1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 3.16E-11 | ||
Tcf7 Tcf7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | ICS | MGP | 3.21E-11 | ||
Tmem189 Tmem189^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 3.31E-11 | ||
Sgms1 Sgms1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 2.32E-10 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 1.06E-9 | ||
Acp2 Acp2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | MRC Harwell | EuroPhenome | 2.48E-9 | ||
Spns2 Spns2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 2.85E-9 | ||
Spns2 Spns2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 2.92E-9 | ||
Acp2 Acp2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | MRC Harwell | EuroPhenome | 4.26E-9 | ||
Parvb Parvb^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | MRC Harwell | EuroPhenome | 6.21E-9 | ||
Spns2 Spns2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 9.28E-9 | ||
Rtbdn Rtbdn^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 1.74E-8 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 1.87E-8 | ||
Usp12 Usp12^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | HMGU | MGP | 2.3E-8 | ||
Arhgef4 Arhgef4^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | HMGU | EuroPhenome | 3.38E-8 | ||
Smc3 Smc3^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 3.38E-8 | ||
Def6 Def6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 5.16E-8 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 1.0E-7 | ||
Nfkb1 Nfkb1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 1.15E-7 | ||
Kdm7a Kdm7a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 1.5E-7 | ||
Hapln4 Hapln4^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 2.0E-7 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell number | WTSI | 3i | 2.0E-7 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 2.0E-7 | ||
Ezr Ezr^{tm2a(EUCOMM)Wtsi} |
HET | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 2.1E-7 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 3.0E-7 | ||
Usp1 Usp1^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 5.0E-7 | ||
Ninj2 Ninj2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 5.24E-7 | ||
Mcf2l Mcf2l^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 7.89E-7 | ||
Cpgi5563 Cpgi5563^{tm1.1(NCC)WCS} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 9.0E-7 | ||
Ehmt1 Ehmt1^{tm1b(EUCOMM)Hmgu} |
HET | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 9.0E-7 | ||
Etv3 Etv3^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 9.0E-7 | ||
Etv3 Etv3^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 9.0E-7 | ||
Tapbpl Tapbpl^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 9.0E-7 | ||
Tnfsf18 Tnfsf18^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 9.0E-7 | ||
Ermap Ermap^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 1.0E-6 | ||
Etv3 Etv3^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 1.0E-6 | ||
Nbeal1 Nbeal1^{tm2b(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 1.0E-6 | ||
Psg26 Psg26^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 1.0E-6 | ||
Clpp Clpp^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 1.2E-6 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell number | WTSI | 3i | 1.4E-6 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 1.4E-6 | ||
Bhlhe40 Bhlhe40^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 1.6E-6 | ||
Gimap6 Gimap6^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 1.6E-6 | ||
Tmod1 Tmod1^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 1.67E-6 | ||
Arhgap22 Arhgap22^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 1.7E-6 | ||
Brpf1 Brpf1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | MRC Harwell | EuroPhenome | 1.89E-6 | ||
Isg20 Isg20^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 1.96E-6 | ||
Ccdc57 Ccdc57^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 2.05E-6 | ||
Sgms1 Sgms1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 2.08E-6 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 2.09E-6 | ||
Acp2 Acp2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | MRC Harwell | EuroPhenome | 3.53E-6 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell number | WTSI | 3i | 3.6E-6 | ||
Arhgap22 Arhgap22^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 3.75E-6 | ||
Smc3 Smc3^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 3.95E-6 | ||
Il27 Il27^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 4.0E-6 | ||
Abhd16a Abhd16a^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 4.1E-6 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 4.1E-6 | ||
Ankhd1 Ankhd1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 5.2E-6 | ||
Tram2 Tram2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 5.85E-6 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell number | WTSI | 3i | 6.3E-6 | ||
Prss50 Prss50^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | MRC Harwell | EuroPhenome | 6.54E-6 | ||
Slc25a21 Slc25a21^{tm1d(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 6.82E-6 | ||
Efcab3 Efcab3^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 7.3E-6 | ||
Mmp11 Mmp11^{tm1a(EUCOMM)Hmgu} |
HET | postnatal | decreased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | HMGU | EuroPhenome | 8.8E-6 | ||
Def6 Def6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 1.05E-5 | ||
Mcf2l Mcf2l^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 1.09E-5 | ||
Cdh23 Cdh23^{tm2b(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 1.39E-5 | ||
Tnik Tnik^{tm3a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 1.45E-5 | ||
Arhgap22 Arhgap22^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 1.65E-5 | ||
Usp3 Usp3^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 1.69E-5 | ||
Fam234b Fam234b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | HMGU | EuroPhenome | 1.82E-5 | ||
Tram2 Tram2^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 1.86E-5 | ||
Cidec Cidec^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | HMGU | EuroPhenome | 1.88E-5 | ||
Dctn1 Dctn1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 1.92E-5 | ||
Cnot4 Cnot4^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | decreased KLRG1+ CD8 alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ KLRG1+ alpha beta T cell number | WTSI | 3i | 2.09E-5 | ||
Bach2 Bach2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 2.12E-5 | ||
Cpgi5563 Cpgi5563^{tm1.1(NCC)WCS} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 2.12E-5 | ||
Cpgi5563 Cpgi5563^{tm1.1(NCC)WCS} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 2.12E-5 | ||
Etv3 Etv3^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 2.12E-5 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell number | WTSI | 3i | 2.12E-5 | ||
Tial1 Tial1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 2.12E-5 | ||
Trim56 Trim56^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD25+ alpha beta regulatory T cell percentage | WTSI | 3i | 2.12E-5 | ||
Zfp84 Zfp84^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell percentage | WTSI | 3i | 2.12E-5 | ||
Hmgb1 Hmgb1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 2.12E-5 | ||
Arpc1b Arpc1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 2.26E-5 | ||
Cpgi5563 Cpgi5563^{tm1.1(NCC)WCS} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 2.26E-5 | ||
Gmds Gmds^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 2.26E-5 | ||
Irgm1 Irgm1^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell number | WTSI | 3i | 2.26E-5 | ||
Zfp84 Zfp84^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ alpha beta T cell percentage | WTSI | 3i | 2.26E-5 | ||
Zfp84 Zfp84^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Total T cell percentage | WTSI | 3i | 2.26E-5 | ||
Zc3hc1 Zc3hc1^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 2.36E-5 | ||
Rreb1 Rreb1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 2.42E-5 | ||
Zfp84 Zfp84^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 2.58E-5 | ||
Rreb1 Rreb1^{tm1b(EUCOMM)Wtsi} |
HET | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 2.75E-5 | ||
Trappc9 Trappc9^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased gamma-delta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Gamma delta T cell percentage | WTSI | 3i | 2.75E-5 | ||
Prss50 Prss50^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | MRC Harwell | EuroPhenome | 2.83E-5 | ||
Aldh2 Aldh2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | MRC Harwell | EuroPhenome | 2.85E-5 | ||
Fbxo7 Fbxo7^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 2.88E-5 | ||
Ciao2a Ciao2a^{tm2a(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 3.1E-5 | ||
Aspm Aspm^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 3.15E-5 | ||
Klhl21 Klhl21^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 3.22E-5 | ||
Aldh2 Aldh2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | FACs Analysis | T cell CD4+ percentage | MRC Harwell | EuroPhenome | 3.3E-5 | ||
Tmod1 Tmod1^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 3.46E-5 | ||
Brd2 Brd2^{em1(IMPC)Wtsi} |
HET | postnatal | decreased KLRG1+ CD8 alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ KLRG1+ alpha beta T cell number | WTSI | 3i | 3.5E-5 | ||
Osbpl3 Osbpl3^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased KLRG1+ CD8 alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ KLRG1+ alpha beta T cell number | WTSI | 3i | 3.5E-5 | ||
Zfp748 Zfp748^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 3.63E-5 | ||
Zc3h14 Zc3h14^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | Alpha beta T cell percentage | WTSI | 3i | 3.77E-5 | ||
Cbx6 Cbx6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 3.85E-5 | ||
Klhl21 Klhl21^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 3.93E-5 | ||
Cpgi5563 Cpgi5563^{tm1.1(NCC)WCS} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 3.95E-5 | ||
Tnfsf18 Tnfsf18^{tm1b(EUCOMM)Hmgu} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 3.95E-5 | ||
Upk1b Upk1b^{tm1b(KOMP)Wtsi} |
HET | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 3.95E-5 | ||
Nfkb1 Nfkb1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD4-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD4+CD44+CD62L- percentage | WTSI | 3i | 3.96E-5 | ||
Gba2 Gba2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 4.61E-5 | ||
Slc5a7 Slc5a7^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 4.71E-5 | ||
Serf1 Serf1^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | MRC Harwell | EuroPhenome | 4.87E-5 | ||
Xbp1 Xbp1^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased T cell number | FACs Analysis | CD25+ percentage of CD4+ T cells | HMGU | EuroPhenome | 5.13E-5 | ||
Lyplal1 Lyplal1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | NKT cell percentage | WTSI | 3i | 5.28E-5 | ||
Elmo1 Elmo1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | Treg cell CD25+ percentage | WTSI | 3i | 5.38E-5 | ||
Eci3 Eci3^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 5.39E-5 | ||
Wrnip1 Wrnip1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | HMGU | EuroPhenome | 5.75E-5 | ||
Tnfrsf1b Tnfrsf1b^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | ICS | MGP | 5.91E-5 | ||
Dlg4 Dlg4^{tm1e(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 6.04E-5 | ||
Tapbpl Tapbpl^{em1(IMPC)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell number | WTSI | 3i | 6.04E-5 | ||
Esco1 Esco1^{tm1(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 6.52E-5 | ||
Duoxa2 Duoxa2^{tm1b(KOMP)Wtsi} |
HOM | postnatal | decreased NK T cell number | Whole blood peripheral blood leukocyte immunophenotyping | NKT cell number | WTSI | 3i | 6.82E-5 | ||
Gper1 Gper1^{tm1Dgen} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | HMGU | EuroPhenome | 6.86E-5 | ||
March5 March5^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 6.92E-5 | ||
Abca4 Abca4^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 6.97E-5 | ||
Aldh2 Aldh2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | MRC Harwell | EuroPhenome | 7.44E-5 | ||
Gper1 Gper1^{tm1Dgen} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | FACs Analysis | T cell CD8+ percentage | HMGU | EuroPhenome | 7.78E-5 | ||
Il27 Il27^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD8+ CD44+ CD62L- alpha beta effector T cell percentage | WTSI | 3i | 7.89E-5 | ||
Sec1 Sec1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 8.21E-5 | ||
Ncf2 Ncf2^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased CD4-positive, alpha beta T cell number | Whole blood peripheral blood leukocyte immunophenotyping | CD4+ alpha beta T cell number | WTSI | 3i | 8.27E-5 | ||
Slc25a21 Slc25a21^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 8.29E-5 | ||
Cidec Cidec^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | HMGU | EuroPhenome | 8.7E-5 | ||
Dbn1 Dbn1^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 8.78E-5 | ||
Dnmt3a Dnmt3a^{tm1a(KOMP)Wtsi} |
HOM | postnatal | decreased effector memory CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | CD8+CD44+CD62L- percentage | WTSI | 3i | 8.9E-5 | ||
Cbx6 Cbx6^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 9.36E-5 | ||
Ezh2 Ezh2^{tm1a(EUCOMM)Wtsi} |
HET | postnatal | decreased CD8-positive, alpha-beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD8+ percentage | WTSI | 3i | 9.72E-5 | ||
Sec1 Sec1^{tm1a(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 9.72E-5 | ||
Slc5a7 Slc5a7^{tm1a(KOMP)Wtsi} |
HET | postnatal | decreased CD4-positive, alpha beta T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD4+ percentage | WTSI | 3i | 9.78E-5 | ||
Eci3 Eci3^{tm1b(EUCOMM)Wtsi} |
HOM | postnatal | decreased T cell number | Buffy coat peripheral blood leukocyte immunophenotyping | T cell CD3+ percentage | WTSI | 3i | 9.83E-5 | ||
Serf1 Serf1^{tm1a(EUCOMM)Hmgu} |
HOM | postnatal | decreased T cell number | FACs Analysis | T cell CD3+ percentage | MRC Harwell | EuroPhenome | 9.87E-5 |